About Apellis Pharmaceuticals, Inc.
Global biopharma company leveraging courageous science, creativity, and compassion to deliver life-changing therapies.
- Industry
- Biotechnology Research
- Company size
- 501-1,000 employees
- Headquarters
- Waltham, MA
- Founded
- 2008
- Company type
- Public Company
- Company profile name
- Apellis Pharmaceuticals
Apellis is now part of Biogen. Please follow along there for the latest news. In the coming weeks, this page will no longer be updated or monitored.
Specialties
- Targeted C3 Therapies
- Complement System
- Hematology
- Ophthalmology
- Nephrology
- Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Geographic Atrophy (GA)
- C3 Glomerulopathy (C3G)
- Gene Therapy
- and Neurology
Company locations
100 Fifth Ave, 3rd Floor, Waltham, MA 02451, US
720 Market Street, 5th Floor, San Francisco, California 94102, US
Zählerweg 10, Zug, 6300, CH
Locations listed on the company profile. These may include offices outside the United States, and not every location is hiring.
Business areas
- Health Care
- Biotechnology
- Pharmaceutical
- Therapeutics
On LinkedIn
- Followers
- 95,501
- People linked to this company
- 575
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Funding raised
919,599,987 USD
Total reported by Crunchbase, in US dollars. This is funding raised, not company revenue or valuation.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.